Standard Chem & Pharm Co Ltd
TWSE:1720
Standard Chem & Pharm Co Ltd
Income from Continuing Operations
Standard Chem & Pharm Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Income from Continuing Operations
NT$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Income from Continuing Operations
NT$1.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Income from Continuing Operations
NT$255.5m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
15%
|
CAGR 10-Years
0%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Income from Continuing Operations
NT$399.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-6%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Income from Continuing Operations
NT$484.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Income from Continuing Operations
NT$4.3B
|
CAGR 3-Years
43%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Standard Chem & Pharm Co Ltd
Glance View
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
See Also
What is Standard Chem & Pharm Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.2B
TWD
Based on the financial report for Sep 30, 2024, Standard Chem & Pharm Co Ltd's Income from Continuing Operations amounts to 1.2B TWD.
What is Standard Chem & Pharm Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
14%
Over the last year, the Income from Continuing Operations growth was 3%. The average annual Income from Continuing Operations growth rates for Standard Chem & Pharm Co Ltd have been 15% over the past three years , 21% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet